CDEX Begins Trading on OTCBB.

NEW YORK -- CDEX Inc. (OTCBB:CEXI.OB), a developer of chemical detection technologies, announced today that it has begun trading on the OTC Bulletin Board, effective immediately.

"Listing on the OTC Bulletin Board should give the Company wider exposure to the investment community and further the process of introducing the company to the market areas that we are targeting," said Malcolm Philips, President and CEO. "We have made a great deal of progress in the health care markets (contracts for multiple products in major hospitals) and the homeland security markets (expanding the development focus to include illegal drugs). We are developing cutting edge solutions to major problems facing this country and are excited about the relationships that we are building for the future."

About CDEX :

CDEX Inc. is a technology development company with a current focus on developing and marketing products using chemical detection and validation technologies. At present, CDEX is devoting its resources to the development of products in two distinct areas: (i) identification of substances of concern (e.g., explosives, illegal drugs and chemical/biological weapons); and (ii) validation of substances for anti-counterfeiting, brand protection and quality assurance (e.g., validation of prescription medication; detection of counterfeit or sub-par products for brand protection; and quality assurance inspection of incoming raw materials and outgoing final products). All CDEX products are based on applying the same underlying technologies for which we have patents pending. CDEX expects to acquire other technologies in the future through partnering and investment. However, at present, the company anticipates that almost all of its revenues, if any, will come from its chemical detection and validation products.

CDEX is headquartered in Rockville, Maryland and has its primary research and development laboratory in Tucson, Arizona. For more information, visit www.cdex-inc.com and www.valimed.com.

Any statements made in this press release which contain information that is not historical are essentially forward-looking. Forward-looking statements can be identified by the use of words such as "expects," "plans," "may," "anticipates," "believes," "should," "intends," "estimates," and other words of similar meaning. These statements are subject to risks and uncertainties that cannot be predicted or quantified and, consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, the ability of the Company to raise capital to finance the development of its chemical detection products, the effectiveness, profitability and the marketability of those products, the ability of the Company to protect its proprietary information, the establishment of an efficient corporate operating structure as the Company grows and, other risks detailed from time-to-time in our filings with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update any forward-looking statements.